Skip to main content
  • Main menu
  • User menu
  • Search

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

Biopharmaceutical Industry Practices for Sequence Variant Analyses of Recombinant Protein Therapeutics

John Valliere-Douglass, Lisa Marzilli, Aparna Deora, Zhimei Du, Luhong He, Sampath R. Kumar, Yan-Hui Liu, Hans-Martin Mueller, Charles Nwosu, John Stults, Yan Wang, Sam Yaghmour and Yizhou Zhou
PDA Journal of Pharmaceutical Science and Technology November 2019, 73 (6) 622-634; DOI: https://doi.org/10.5731/pdajpst.2019.010009
John Valliere-Douglass
1Seattle Genetics Inc., Bothell, WA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jdouglass@seagen.com
Lisa Marzilli
2Pfizer Inc., Andover, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aparna Deora
3Pfizer Inc., Chesterfield, MO;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhimei Du
4Merck & Co., Inc., Kenilworth, NJ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luhong He
5Eli Lilly & Company, Indianapolis, IN;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sampath R. Kumar
6Takeda Pharmaceuticals, Cambridge, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan-Hui Liu
4Merck & Co., Inc., Kenilworth, NJ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Martin Mueller
7Merck Sharp & Dohme AG, Lucerne, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Nwosu
6Takeda Pharmaceuticals, Cambridge, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Stults
8Genentech Inc., South San Francisco, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan Wang
10Takeda Pharmaceuticals, Lexington, MA; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sam Yaghmour
11Amgen Inc., Thousand Oaks, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yizhou Zhou
9Biogen Inc., Cambridge, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    U.S. Food and Drug Administration. Guidance for Industry Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. U.S. Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), 1999: https://www.fda.gov/media/71510/download.
    Google Scholar
  2. 2.↵
    1. Lian Z.,
    2. Wu Q.,
    3. Wang T.
    Identification and Characterization of a-1 Reading Frameshift in the Heavy Chain Constant Region of an IgG1 Recombinant Monoclonal Antibody Produced in CHO Cells. mAbs 2016, 8 (2), 358–370.
    OpenUrlGoogle Scholar
  3. 3.↵
    1. Wan M.,
    2. Shiau F. Y.,
    3. Gordon W.,
    4. Wang G. Y.
    Variant Antibody Identification by Peptide Mapping. Biotechnol. Bioeng. 1999, 62 (4), 485–488.
    OpenUrlPubMedGoogle Scholar
  4. 4.↵
    1. Zhang Z.,
    2. Shah B.,
    3. Bondarenko P. V.
    G/U and Certain Wobble Position Mismatches as Possible Main Causes of Amino Acid Misincorporations. Biochemistry 2013, 52 (45), 8165–8176.
    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
  5. 5.↵
    1. Feeney L.,
    2. Carvalhal V.,
    3. Yu X. C.,
    4. Chan B.,
    5. Michels D. A.,
    6. Wang Y. J.,
    7. Shen A.,
    8. Ressl J.,
    9. Dusel B.,
    10. Laird M. W.
    Eliminating Tyrosine Sequence Variants in CHO Cell Lines Producing Recombinant Monoclonal Antibodies. Biotechnol. Bioeng. 2013, 110 (4), 1087–1097.
    OpenUrlCrossRefGoogle Scholar
  6. 6.↵
    1. Fu J.,
    2. Bongers J.,
    3. Tao L.,
    4. Huang D.,
    5. Ludwig R.,
    6. Huang Y.,
    7. Qian Y.,
    8. Basch J.,
    9. Goldstein J.,
    10. Krishnan R.,
    11. You L.,
    12. Li Z. J.,
    13. Russell R. J.
    Characterization and Identification of Alanine to Serine Sequence Variants in an IgG4 Monoclonal Antibody Produced in Mammalian Cell Lines. J. Chromatogr. B 2012, 908, 1–8.
    OpenUrlGoogle Scholar
  7. 7.↵
    1. Zeck A.,
    2. Regula J. T.,
    3. Larraillet V.,
    4. Mautz B.,
    5. Popp O.,
    6. Gopfert U.,
    7. Wiegeshoff F.,
    8. Vollertsen U. E.,
    9. Gorr I. H.,
    10. Koll H.,
    11. Papadimitriou A.
    Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized Approach. PloS One 2012, 7 (7), e40328.
    OpenUrlPubMedGoogle Scholar
  8. 8.↵
    1. Zhang S.,
    2. Bartkowiak L.,
    3. Nabiswa B.,
    4. Mishra P.,
    5. Fann J.,
    6. Ouellette D.,
    7. Correia I.,
    8. Regier D.,
    9. Liu J.
    Identifying Low-Level Sequence Variants via Next Generation Sequencing to Aid Stable CHO Cell Line Screening. Biotechnol. Prog. 2015, 31 (4), 1077–1085.
    OpenUrlGoogle Scholar
  9. 9.↵
    1. Wright C.,
    2. Groot J.,
    3. Swahn S.,
    4. McLaughlin H.,
    5. Liu M.,
    6. Xu C.,
    7. Sun C.,
    8. Zheng E.,
    9. Estes S.
    Genetic Mutation Analysis at Early Stages of Cell Line Development Using Next Generation Sequencing. Biotechnol. Prog. 2016, 32 (3), 813–817.
    OpenUrlGoogle Scholar
  10. 10.↵
    1. Yu X. C.,
    2. Borisov O. V.,
    3. Alvarez M.,
    4. Michels D. A.,
    5. Wang Y. J.,
    6. Ling V.
    Identification of Codon-Specific Serine to Asparagine Mistranslation in Recombinant Monoclonal Antibodies by High-Resolution Mass Spectrometry. Anal. Chem. 2009, 81 (22), 9282–9290.
    OpenUrlCrossRefPubMedGoogle Scholar
  11. 11.↵
    1. Yates J. R.,
    2. Speicher S.,
    3. Griffin P. R.,
    4. Hunkapiller T.
    Peptide Mass Maps: A Highly Informative Approach to Protein Identification. Anal. Biochem. 1993, 214 (2), 397–408.
    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
  12. 12.↵
    1. Pappin D. J.,
    2. Hojrup P.,
    3. Bleasby A. J.
    Rapid Identification of Proteins by Peptide-Mass Fingerprinting. Cur.r Biol. 1993, 3 (6), 327–332.
    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
  13. 13.↵
    1. Henzel W. J.,
    2. Billeci T. M.,
    3. Stults J. T.,
    4. Wong S. C.,
    5. Grimley C.,
    6. Watanabe C.
    Identifying Proteins from Two-Dimensional Gels by Molecular Mass Searching of Peptide Fragments in Protein Sequence Databases. Proc. Natl. Acad. Sci. U.S.A. 1993, 90 (11), 5011–5015.
    OpenUrlAbstract/FREE Full TextGoogle Scholar
  14. 14.↵
    1. Eng J. K.,
    2. McCormack A. L.,
    3. Yates J. R.
    An Approach to Correlate Tandem Mass Spectral Data of Peptides with Amino Acid Sequences in a Protein Database. J. Am. Soc. Mass Spectrom. 1994, 5 (11), 976–989.
    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
  15. 15.↵
    1. Schiel J. E.,
    2. Davis D. L.,
    3. Borisov O. V.
    1. Borisov O. V.,
    2. Alvarez M.,
    3. Carroll J. A.,
    4. Brown P. W.
    Sequence Variants and Sequence Variant Analysis in Biotherapeutic Proteins. In State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study; Schiel J. E., Davis D. L., Borisov O. V., Eds.; ACS Symposium Series 1201; American Chemical Society, 2015; pp 63–117, Chapter 2.
    Google Scholar
  16. 16.↵
    1. Yang Y.,
    2. Strahan A.,
    3. Li C.,
    4. Shen A.,
    5. Liu H.,
    6. Ouyang J.,
    7. Katta V.,
    8. Francissen K.,
    9. Zhang B.
    Detecting Low Level Sequence Variants in Recombinant Monoclonal Antibodies. mAbs 2010, 2 (3), 285–298.
    OpenUrlPubMedGoogle Scholar
  17. 17.↵
    1. Harris R. J.,
    2. Murnane A. A.,
    3. Utter S. L.,
    4. Wagner K. L.,
    5. Cox E. T.,
    6. Polastri G. D.,
    7. Helder J. C.,
    8. Sliwkowski M. B.
    Assessing Genetic Heterogeneity in Production Cell Lines: detection by Peptide Mapping of a Low Level Tyr to Gln Sequence Variant in a Recombinant Antibody. Nat. Biotechnol. 1993, 11, 1293–1297.
    OpenUrlGoogle Scholar
  18. 18.↵
    1. Li W.,
    2. Wypych J.,
    3. Duff R. J.
    Improved Sequence Variant Analysis Strategy by Automated False Positive Removal. mAbs 2017, 9 (6), 978–984.
    OpenUrlGoogle Scholar
  19. 19.↵
    1. Wen D.,
    2. Vecchi M. M.,
    3. Gu S.,
    4. Su L.,
    5. Dolnikova J.,
    6. Huang Y. M.,
    7. Foley S. F.,
    8. Garber E.,
    9. Pederson N.,
    10. Meier W.
    Discovery and Investigation of Misincorporation of Serine at Asparagine Positions in Recombinant Proteins Expressed in Chinese Hamster Ovary Cells. J. Biol. Chem. 2009, 284 (47), 32686–32694.
    OpenUrlAbstract/FREE Full TextGoogle Scholar
  20. 20.↵
    1. Ren D.,
    2. Zhang J.,
    3. Pritchett R.,
    4. Liu H.,
    5. Kyauk J.,
    6. Luo J.,
    7. Amanullah A.
    Detection and Identification of a Serine to Arginine Sequence Variant in a Therapeutic Monoclonal Antibody. J. Chromatogr. B 2011, 879 (27), 2877–2884.
    OpenUrlGoogle Scholar
  21. 21.↵
    1. Zhang J.,
    2. Chiodini R.,
    3. Badr A.,
    4. Zhang G.
    The Impact of Next-Generation Sequencing on Genomics. J. Genet. Genomics 2011, 38 (3), 95–109.
    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
  22. 22.↵
    U.S. Food and Drug Administration. Guidance for Stakeholders and Food and Drug Administration Staff: Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based in Vitro Diagnostics. U.S. Department of Health and Human Services Food and Drug Administration. Center for Devices and Radiological Health, 2018; https://www.fda.gov/media/99200/download.
    Google Scholar
  23. 23.↵
    U.S. Food and Drug Administration. Guidance for Stakeholders and Food and Drug Administration Staff: Considerations for Design, Development, and Analytical Validation of Next Generation Sequencing (NGS) – Based In Vitro Diagnostics (IVDs) Intended to Aid in the Diagnosis of Suspected Germline Diseases. U.S. Department of Health and Human Services Food and Drug Administration. Center for Devices and Radiological Health, 2018; https://www.fda.gov/media/99208/download.
    Google Scholar
  24. 24.↵
    1. Voelkerding K. V.,
    2. Dames S. A.,
    3. Durtschi J. D.
    Next-Generation Sequencing: From Basic Research to Diagnostics. Clin. Chem. 2009, 55 (4), 641–658.
    OpenUrlAbstract/FREE Full TextGoogle Scholar
  25. 25.↵
    1. Lin T. J.,
    2. Beal K. M.,
    3. Brown P. W.,
    4. DeGruttola H. S.,
    5. Ly M.,
    6. Wang W.,
    7. Chu C. H.,
    8. Dufield R. L.,
    9. Casperson G. F.,
    10. Carroll J. A.,
    11. Friese O. V.,
    12. Figueroa B. Jr..,
    13. Marzilli L. A.,
    14. Anderson K.,
    15. Rouse J. C.
    Evolution of a Comprehensive, Orthogonal Approach to Sequence Variant Analysis for Biotherapeutics. mAbs 2019, 11 (1), 1–12.
    OpenUrlGoogle Scholar
  26. 26.↵
    1. Lin T. J.,
    2. Beal K. M.,
    3. DeGruttola H. S.,
    4. Brennan S.,
    5. Marzilli L. A.,
    6. Anderson K.
    Utilization of Sequence Variants as Biomarkers to Analyze Population Dynamics in Cloned Cell Lines. Biotechnol. Bioeng. 2017, 114 (8), 1744–1752.
    OpenUrlGoogle Scholar
  27. 27.↵
    1. Guo D.,
    2. Gao A.,
    3. Michels D. A.,
    4. Feeney L.,
    5. Eng M.,
    6. Chan B.,
    7. Laird M. W.,
    8. Zhang B.,
    9. Yu X. C.,
    10. Joly J.,
    11. Snedecor B.,
    12. Shen A.
    Mechanisms of Unintended Amino Acid Sequence Changes in Recombinant Monoclonal Antibodies Expressed in Chinese Hamster Ovary (CHO) Cells. Biotechnol. Bioeng. 2010, 107 (1), 163–171.
    OpenUrlCrossRefPubMedGoogle Scholar
  28. 28.↵
    1. Wong H. E.,
    2. Huang C. J.,
    3. Zhang Z.
    Amino Acid Misincorporation in Recombinant Proteins. Biotechnol Adv. 2018, 36 (1), 168–181.
    OpenUrlGoogle Scholar
  29. 29.↵
    1. Khetan A.,
    2. Huang Y. M.,
    3. Dolnikova J.,
    4. Pederson N. E.,
    5. Wen D.,
    6. Yusuf-Makagiansar H.,
    7. Chen P.,
    8. Ryll T.
    Control of Misincorporation of Serine for Asparagine during Antibody Production Using CHO Cells. Biotechnol. Bioeng. 2010, 107 (1), 116–123.
    OpenUrlPubMedGoogle Scholar
  30. 30.↵
    1. Ni J.,
    2. Gao M.,
    3. James A.,
    4. Yao J.,
    5. Yuan T.,
    6. Carpick B.,
    7. D'Amore T.,
    8. Farrell P.
    Investigation into the Misincorporation of Norleucine into a Recombinant Protein Vaccine Candidate. J. Ind. Microbiol. Biotechnol. 2015, 42 (6), 971–975.
    OpenUrlGoogle Scholar
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 73 (6)
PDA Journal of Pharmaceutical Science and Technology
Vol. 73, Issue 6
November/December 2019
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Biopharmaceutical Industry Practices for Sequence Variant Analyses of Recombinant Protein Therapeutics
John Valliere-Douglass, Lisa Marzilli, Aparna Deora, Zhimei Du, Luhong He, Sampath R. Kumar, Yan-Hui Liu, Hans-Martin Mueller, Charles Nwosu, John Stults, Yan Wang, Sam Yaghmour, Yizhou Zhou
PDA Journal of Pharmaceutical Science and Technology Nov 2019, 73 (6) 622-634; DOI: 10.5731/pdajpst.2019.010009
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget

Jump to section

  • Article
    • Abstract
    • Introduction
    • Survey Methodology and Scope
    • Summary of the Survey Results
    • Mass Spectrometry (MS)
    • Next-Generation Sequencing
    • Discussion
    • Conclusion
    • Conflict of Interest Declaration
    • Acknowledgements
    • Appendix
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Challenges and Solutions to Manufacturing of Low-Viscosity, Ultra-High Concentration IgG1 Drug Products: From Late Downstream Process to Final Fill Finish Processing
  • Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
  • Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
Show more Commentary

Similar Articles

Keywords

  • Amino acid sequence variants
  • Amino acid substitution
  • Codon wobble
  • Mass spectrometry
  • Next-generation sequencing
  • Clone screening

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biopharmaceutical Industry Practices for Sequence Variant Analyses of Recombinant Protein Therapeutics
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Biopharmaceutical Industry Practices for Sequence Variant Analyses of Recombinant Protein Therapeutics
John Valliere-Douglass, Lisa Marzilli, Aparna Deora, Zhimei Du, Luhong He, Sampath R. Kumar, Yan-Hui Liu, Hans-Martin Mueller, Charles Nwosu, John Stults, Yan Wang, Sam Yaghmour, Yizhou Zhou
PDA Journal of Pharmaceutical Science and Technology Nov 2019, 73 (6) 622-634; DOI: 10.5731/pdajpst.2019.010009

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.